WeVote
Log In

Bill

Bill

SB 889

Relating to: immunity for certain controlled substances offenses for aiders and aided persons.

2025-2026 Regular Session Introduced by Rachael Cabral-Guevara and 1 co-sponsor

SB 889 would grant immunity from certain charges to people who aid or are aided in a controlled substances offense, encouraging timely help while limiting scope and abuse.

Failed to pass pursuant to Senate Joint Resolution 1
0
WeVote Research Nonpartisan
Bill Summary · SB 889

Summary of Wisconsin Senate Bill 889 (2025 Session)

Title

Relating to immunity for certain controlled substances offenses for aiders and aided persons.

Purpose and intent

SB 889 proposes to grant immunity from prosecution or certain penalties for specified offenses involving controlled substances, specifically in situations where one person (an aider) assists another (an aided person) in the commission of a controlled substances offense. The bill aims to encourage timeliness of seeking help and reduce barriers to reporting or assisting without fear of criminal liability for certain related offenses.

Key provisions (highlights)

  • Immunity scope: Provides immunity for specific controlled substances offenses in which one person aids another in the unlawful activity. The precise offenses and the breadth of immunity (e.g., whether it applies to possession, distribution, manufacturing, or paraphernalia-related charges) are defined in the bill text (not reproduced here). The language suggests a focus on aiding and aided persons rather than all participants in a drug offense.
  • Eligibility criteria: Immunity would apply only to individuals who meet defined criteria as “aiders” and “aided persons.” Typically, such provisions require that the aider acted with certain intent, purposes (e.g., seeking medical help, ensuring safety, or other non-violent intent), or that the aided person was in need of assistance (e.g., overdose or medical distress). The bill would establish conditions under which immunity applies and may exclude cases involving violent crime or certain aggravating factors.
  • Malice and intent limitations: The immunity is usually limited to offenses connected to the aiding activity and may not extend to offenses beyond the scope of the aiding act, or to cases involving harm to others or violent criminal activity.
  • No double recovery: The provisions may include standard limitations that immunity does not prevent other related charges (e.g., for possession of weapons or trafficking unrelated to the aiding act) or negate other penalties if per se required by other statutes.

Note: The exact statutory text would specify the precise offenses covered, any required actions (e.g., contacting emergency services), and any exceptions or conditions.

Affected parties

  • Aiders: Individuals who assist or facilitate another person’s controlled substances offense.
  • Aided persons: Individuals who receive aid or assistance in the commission or avoidance of a controlled substances offense.
  • Law enforcement and prosecutors: Immunity provisions alter charging decisions and potential penalties in covered cases, and may require adjustments to prosecutorial discretion and case handling.
  • Public health and service organizations: Groups focused on overdose response and harm reduction may be impacted by changes in enforcement risk, potentially affecting outreach and intervention strategies.

Procedural and timeline aspects

  • Introduced: January 27, 2026, by Senators James and Cabral-Guevara.
  • Cosponsors: Included both Senate and House members, with initial cosponsorship by Representatives Dittrich, Armstrong, Clancy, Doyle, Gundrum, Knodl, Madison, Snodgrass, Stubbs, and others; later updates show additional cosponsorship.
  • Committee: Referred to the Committee on Mental Health, Substance Abuse Prevention, Children and Families for a public hearing (noted as held on March 3, 2026).
  • Legislative progress: Action history indicates attempts to pass via Senate Joint Resolution 1 on March 23, 2026 (not successful). This suggests the bill may have faced procedural hurdles or failed to advance during that session, though details would require the final status in the session records.
  • Lobbying and advocacy: Several advocacy groups (e.g., ACLU of Wisconsin, DreamsCorps, League of Women Voters of Wisconsin, Pew Charitable Trusts, Vivent Health, Wisconsin Association for the Treatment of Opioid Dependence, Wisconsin Public Health Association) are listed as supporters or participants in the discussion, signaling public health and civil liberties interest in the measure.

Potential impact and considerations

  • Public health rationale: Immunity for aiders and aided persons can reduce barriers to seeking help during overdoses or drug-related emergencies, potentially saving lives by encouraging call-for-help and timely assistance.
  • Criminal justice considerations: The bill shifts certain liability dynamics, balancing punishment with harm-reduction aims. It may reduce prosecutions for ancillary offenses in urgent assistance scenarios.
  • Safeguards: Effective implementation depends on clear definitions of eligible acts, conditions for immunity, and concrete limitations to prevent abuse (e.g., ensuring immunity does not cover violent or harmful activities beyond the aiding act).

Overall assessment

SB 889 seeks to promote safety and public health by providing targeted immunity for participants in controlled substances offenses who aid or are aided by others in distress or seeking help. The measure emphasizes harm reduction and timely emergency response, while maintaining defined boundaries to prevent misuse. The bill underwent committee review and had various supporters, but as of the latest action history, it did not pass via the specified procedural path in the session.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.